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1. Introduction 
One of the main obstacles to the analysis of peptide 
action at the cellular level is the design of radioactive 
labeling procedures which do not significantly alter 
the biological activity of the labeled peptide. Of the 
two isotopes commonly used to obtain compounds 
of high specific radioactivity (3H, 1251), only tritium 
labeling produces true tracers without modification 
of physical or chemical properties. However, since 
suitable unsaturated orhalogenated precursors for 
catalytic reduction with tritium gas can only be 
obtained in a few exceptional cases, iodination is the 
method commonly employed. The resulting difficul- 
ties associated with the production of an analog have 
been well documented for insulin and glucagon 
[l-5] , and even more clearly for angiotensin and 
posterior pituitary hormones [6-91. 
The recent discovery and isolation of a novel 
bacterial hemoprotein enzyme, named indolyl3- 
alkane cr-hydroxylase [IO] , suggested an alternative 
and partially enzymatic approach to labeling of 
proteins and peptides. The enzyme catalyzes the 
formation of an unsaturated intermediate (3.alkyli- 
dene indoline) which can be isolated if both the 
carboxy and a-amino group of tryptophan are pro- 
tected by substitution [ 1 I] . 
In this paper we present a summary of new obser- 
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vations that bear on the reaction mechanism of the 
enzyme and describe its application to the formation 
of an aliphatic double bond specifically in tryptophan 
residues of peptides and proteins. This double bond 
reacts readily with ICI and iodine and it can also be 
reduced catalytically with hydrogen and hydrogen 
isotopes. 
2. Materials 
The chemicals used in this work were obtained 
from the following sources: all indole derivatives, 
gastrin related peptide, adrenocorticotrophic ormone 
(ACTH), egg white lysozyme and myoglobin from 
Sigma; Sephadex gels from Pharmacia; urea and 
dithiothreitol from Biorad; hydrogenation catalysts 
and all buffer chemicals from Merck (Darmstadt). The 
enzyme was isolated from Pseudomonas and purified 
to homogeneity as in [lo] . The a-neurotoxin from 
Naja naja siamensis was purified as in [ 121. Plasmin- 
ogen activator was a gift of Drs E. Reich and H.-D. 
Schleuning, The Rockefeller University, New York,, 
Synacthen (Tetracosactid hexaacetate) which struc- 
turally is identical with ACTH l-24 was a gift of 
CibaGeigy, Switzerland. ACTH (from Sigma) 
yielded several bands by polyacrylamide gel electro- 
phoresis; the chemical purity was approx. 70-80%. 
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3. Results and discussion 
3.1. N-Acetyl-L-tryptophanamide substrate 
To define optimal experimental conditions for 
modifying peptides, we first investigated the enzyme’s 
action on model compounds, in particular N-acetyl- 
Ltryptophanamide. The results, which will be pub- 
lished in detail elsewhere, xtend the data [lo,1 1,13, 
141 but focus mainly on the reactivity of the reaction 
products rather than on the mechanism of the 
enzymatic reaction. 
The enzymatic reaction is accompanied by changes 
in ultraviolet absorption [11,131 and fluorescence 
[ 151 of the indole substrates. With N-acetyl-Ltrypto- 
phanamide as substrate anew absorption band with 
maximum at 333 nm was formed (tig.1). No isosbestic 
points were detected [11,131 even when the enzyme 
was removed from the reaction mixture by gel 
permeation chromatography. The ultraviolet spectrum 
of the product(s) depended upon the pH at which the 
reaction occurred and upon the buffer composition 
and concentration i  a rather complex manner 
[ 15,161. For example, the A333 nm/276 nm varied from 
about 0.5 for reaction in 0.05 M sodium acetate 
buffer, pH 3.5, to a maximum of about 2.2 M for 
0.05 M potassium phosphate buffer, pH 7.0. When 
incubated with the enzyme, the typical indole fluores- 
cence emission band with maximum (uncorrected) at 
352 nm progressively diminished and was replaced by 
a weak new emission band with maximum at 396 nm 
(for excitation at 333 nm) [ 151. Throughout he 
reaction, the enzyme’s intrinsic fluorescence spectrum 
with maximum at 323 run was not changed indicating 
that its tryptophan residues in their rather hydro- 
phobic environment were not also substrates of the 
enzyme [ 151. 
Using ultraviolet absorption and fluorescence as 
monitoring parameters we have analyzed the solvent 
conditions of the enzymatic reaction and have studied 
iodination and catalytic hydrogenation of the result- 
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Fig.lA. Ultraviolet absorption spectra of N-acetyl-L-tryptophanamide,_its enzymatic reaction product and reaction of the latter 
with ICY. N-Acetyl-tryptophanamide (3.6 X 10-s M) was reacted at 25°C with 3 pg of puriiied enzyme in 1 ml 0.05 M potassium 
phosphate buffer, pH 7.0. Spectra were recorded before addition of enzyme (- - -) and after completion of the reaction (----). 
The spectraIratioA,,,/,,, remained constant even after removal of the enzyme by gel permeation chromatography using Sephadex 
G-25. Reaction with ICI: Before addition of ICl to an aliquot of peak VI of the chromatographic separation of fglB, the reaction 
mixture had the same A Jss as (-). ICI, 2 X lo-* mol, were added to the didehydrotryptophan derivative in 1 ml of 0.05 M 
potassium phosphate buffer, pH 7.0 (. . .). Sample and reference cuvette were not matched in this experiment. Fig.lB. Gel permea- 
tion chromatography on Sephadex G-25 of the reaction mixture. N-acetyltryptophanamide, 12 mg, were reacted at 25°C with 
25 pg of purified enzyme in total vol. 4.05 ml 0.025 M Tris-HCl buffer, pH 7.2. After 30 h the reaction mixture was applied to 
a column (1.5 X 30 cm) of Sephadex G-25 equilibrated with H,O. Fractions of 50 drops were taken. Peak I (void vol.) contained 
the enzyme while all other products were of low molecular weights. Peaks III and IV showed ultraviolet A,,, max, peak V con- 
tained unreacted N-acetyltryptophanamide and peak VI, the major reaction product, was identified as 3-alkylidene-lndoline 
derivative by its spectral properties and reactivity to ICI. 
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ing products. For the latter studies we have separated 
the enzyme from the products by Sephadex G-10 or 
G-25 chromatography (fig. 1); this procedure led to 
the resolution of several minor products both from 
unreacted N-acetyl-Ltryptophanamide and from the 
main reaction product, the latter being retarded 
significantly more than the unchanged substrate. 
These were our findings: 
(9 
(ii) 
The enzyme was active over a wide range of pH 
values, in 8 M urea and in 0.25-l .% sodium 
dodecylsulfate solution at pH 7. 
The main reaction product did not react with 
sodium borohydride [13,154 but did react with 
both ICl and IZ [ 151. Reaction with ICI resulted 
in an almost complete disappearance of the long 
wavelength ultraviolet absorption band without 
reappearance of the original spectrum of N-acetyl- 
Ltryptophananamide (iIg.1). Titration of excess 
ICl with sodium dithionite showed that there 
existed approx. 0.8 mol olefinic double bond/m01 
reaction product [ 151. 
(iii) The reaction product was susceptible to catalytic 
hydrogenation [ 131. Reduction of the double 
bond occurred readily with PdO as catalyst but 
only much more slowly with PtO, . xHzO or 
Pd-charcoal [ 151. Hydrogenation was accom- 
panied by the disappearance of the long-wave- 
length absorption band and simultaneous reappear- 
auce of the spectrum of the initial substrate 
N-acetyl-L-tryptophanamide (fig.1). However, we 
never succeeded in completely converting the 
enzyme’s reaction products into the initial sub- 
strate, probably because of the occurrence of side 
reactions (frg.1). 
The enzyme acted by the same mechanism on a 
variety of indole3-alkanes including 34ndole propionic 
acid,~34ndoleacetic ac d [15] and skatole [ 1 l] ; this 
was also so for a large number of tryptophan contain- 
ing di- and tri-peptides [ 13,151. While we were able 
to establish the formation of an aliphatic double bond 
in all of these by reaction with ICl and/or catalytic 
hydrogenation, the reaction usually progressed further 
as indicated by consecutive spectral shifts. Stable 
didehydrotryptophan derivatives were only obtained 
if both the carboxyl and a-amino groups were substi- 
tuted [15]. 
The above data confirm the formation of an olefinic 
double bond during the enzymatic reaction [ 11,131 
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Fig.2. Chemical structure of products identified after reaction 
of indolyl-3-alkane ar-hydroxylase with N-acetyltryptophan- 
amide. The 3-alkylidene lndoline (II) has been shown by mass 
spectrometry and NMR to be the initial product of the 
enzymatic reaction at pH 5.5 [ 111. In addition several other 
products were identified in the reaction mixture, another 
major one being the oxazoline derivative III [ 1 l] . Upon addi- 
tion of acid to the reaction mixture one major product, the 
o-bdidehydro derivative IV, was formed [ 1 l] which is 
structurally identical with the unsaturated product isolated 
[131. 
and lend support o the proposal [1 I] that compound 
II (fig.2) but not IV [ 131 is the initial intermediate 
of the enzymatic reaction. 
3.2. Peptide substrates 
Once the action of indolyl3alkane hydroxylase 
on N-acetyl-Ltryptophanamide had been analyzed, 
its application for modifying peptides and proteins 
became feasible. These studies howed that peptides 
are generally much less efficient substrates than 
simpler indole derivatives and, in some cases, did not 
react at all. A prominent example of the latter case 
was cobra cu-neurotoxin [ 121 which neither eacted 
in buffer at pH 7 nor pH 5, nor in 8 M urea or 1% 
SDS. However, after reduction of some of its disulfide 
bonds by mercaptoethanol, the single tryptophan 
residue became susceptible to enzymatic attack in 
8 M urea and yielded a reaction product which, after 
reoxidation of the cysteines, readily reacted with ICI. 
In contrast o the apparently rather igidly struc- 
tured a-neurotoxin (5 S-S bridges, 72 amino acids), 
adrenocorticotrophic hormone (ACTH, 39 amino 
acids, no S-S bridges) was a good substrate of the 
enzyme. To achieve areaction rate with ACTH similar 
to that with N-acetyl-Ltryptophanamide required 
approx. 20-times more enzyme (substrate concentra- 
tion in both cases 5 X IO-’ M, phosphate buffer, 
pH 7.0). As withN-acetyl-tryptophanamide, a new 
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Fig.3. Ultraviolet absorption spectra of ACTH, its enzymatic 
reaction product and the product after partial hydrogenation. 
ACTH (5.5 X lo-’ M) was reacted at 25°C with 50 pg puri- 
fied enzyme in 1.1 ml 0.05 phosphate buffer, pH 7.0 until 
completion (3 h). Spectra were recorded before addition of 
enzyme (-. .-) and at the end of the reaction (-_). Cata- 
lytic hydrogenation was carried out in the cuvette with 1 mg 
PdO as catalyst. (-- - -) Spectrum after 20 min reduction, 
( . . . . ) spectrum after 90 min reduction. Spectra were mea- 
sured in presence of enzyme and are not corrected for the 
absorbance of the enzyme. 
absorption band with maximum at 336 nm developed, 
A336/2,5 was, however, much smaller than for the 
former product. The intrinsic indole fluorescence of 
ACTH was also abolished. As described for the dide- 
hydrotryptophan derivatives, when the unsaturated 
product was reacted with ICl and Ia, at pH 7, there 
were large changes in the indole absorption spectrum, 
but since ACTH contains a histidine and two tyrosine 
residues besides tryptophan, these are likely also to 
have been altered, and we have in fact established that 
extensive product heterogeneity is obtained on iodina- 
tion [IS] . In contrast, as seen in fig.3, a partial 
catalytic reduction of the enzymatic reaction product 
using PdO as catalyst gave minor heterogeneity with 
over 80% reduced product consisting of a single 
species inseparable by column chromatography from 
authentic ACTH. Other effective substrates found so 
far include: poly(D,L-tryptophan), tryptophylalanine, 
tryptophyltyrosine, and L-tryptophyl-methionyl- 
aspartyl-phenylalanineamide. The gastrin related 
peptide tert-amyloxycarbonyl-L-tryptophyl-L 
methionyl-L-aspartyl-Lphenylalanine amide was a 
good substrate for the enzyme and the reaction 
product was easily hydrogenated to regenerated 
starting material. Chicken egg-white lysozyme reacted 
only partially (less than 20%) under non-reducing 
conditions. The largest polypeptide tested to date 
was myoglobin, which reacted best in 8 M urea. 
4. Conclusion 
Indolyl3-alkane cw-hydroxylase is a novel catalyst 
suitable for the preparation of didehydrotryptophan 
residues in peptides and proteins. The resulting double 
bond reacts readily with ICl or Ia; it is also susceptible 
to catalytic hydrogenation and deuteration and, by 
inference, tritiation. Since tritium is obtainable in 
carrier-free form, specific radioactivities of 56 Ci/mmol 
reacted tryptophan residue should be obtainable with 
little difficulty [ 171 and at low cost. 
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